Gene therapy for glioblastoma: future perspective for delivery systems and molecular targets.
Shir
A
A
Department of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Israel. alexeis@cc.huji.ac.il
Levitzki
A
A
D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000235:genetics; D001932:Brain Neoplasms / Q000235:genetics / Q000628:therapy*; D018816:Genes, cdc / Q000187:drug effects / Q000502:physiology; D015316:Genetic Therapy / Q000379:methods* / Q000639:trends*; D005822:Genetic Vectors / Q000235:genetics* / Q000627:therapeutic use*; D005909:Glioblastoma / Q000235:genetics / Q000628:therapy*; D006801:Humans; D014780:Viruses / Q000235:genetics; D019892:eIF-2 Kinase / Q000187:drug effects / Q000235:genetics / Q000378:metabolism
D019892:eIF-2 Kinase